SCHEMBL23919144

SCHEMBL23919144

COc1ccc(C2(c3ccc(OC)cc3)C=Cc3c(c4cc(OC)c(OC)cc4c4c5ccccc5n(-c5ccccc5)c34)O2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.35
MAPT P10636 5/20 0.35
NPSR1 Q6W5P4 1/20 0.35
EDNRA P25101 3/20 0.34
ALDH1A1 P00352 4/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TP53 P04637 1/20 0.32
HTT P42858 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
ATM Q13315 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
POLB P06746 1/20 0.31
HPGD P15428 4/20 0.31
HSD17B10 Q99714 2/20 0.31
KDR P35968 1/20 0.31
LMNA P02545 2/20 0.31
PTK2B Q14289 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919130 0.97 MAPT (0.36) KDM4EMAPTNPSR1EDNRAALDH1A1
SCHEMBL22145205 0.91 EDNRA (0.34) KDM4EMAPTEDNRAALDH1A1SMN1; SMN2
SCHEMBL22145250 0.91 KDM4E (0.36) KDM4EMAPTEDNRAALDH1A1SMN1; SMN2
SCHEMBL22145201 0.88 MAPT (0.36) KDM4EMAPTEDNRAALDH1A1SMN1; SMN2
SCHEMBL22145135 0.88 EDNRA (0.36) KDM4EMAPTNPSR1EDNRAALDH1A1
SCHEMBL22145217 0.87 MAT2A (0.39) ALDH1A1POLBPPARG
SCHEMBL22145207 0.87 KDM4E (0.33) KDM4EMAPTEDNRAALDH1A1SMN1; SMN2
SCHEMBL23919153 0.86 POLB (0.36) KDM4EMAPTNPSR1ALDH1A1SMN1; SMN2
SCHEMBL22145210 0.84 ALDH1A1 (0.31) KDM4EMAPTEDNRAALDH1A1TP53
SCHEMBL22145208 0.84 SMN1; SMN2 (0.35) KDM4EMAPTEDNRAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317129-A1 Indolenaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317129-A1 Indolenaphthopyrans AHR, TDO2, TPH2 KDM4E 3276/4885MAPT 3512/4885NPSR1 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.